Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US grocery chain offers Home Diagnostics' glucose meters

This article was originally published in Clinica

Executive Summary

US grocer Wegmans Food Markets is launching its first glucose monitoring systems for diabetics, TRUEresult and TRUE2go. The monitors will carry the shop's branding and will be supplied by Nipro Diagnostics (previously Home Diagnostics), which originally developed the device. The launch reflects a trend towards greater availability of point-of-care tests outside the conventional settings such as hospitals or doctors' surgeries, and the direct targeting of consumers by IVD companies. This segment is expected to grow as it offers consumers greater convenience. TRUEresult and TRUE2go received 510(k) clearance from the US FDA in 2008 (www.clinica.co.uk, 21 August 2010). TRUEresult will be sold in Wegmans for $19.99 and the smaller TRUE2go device for $8.99. Wegmans operates 77 stores in New York, Pennsylvania, New Jersey, Virginia and Maryland.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT096008

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel